Veracyte (VCYT) News Today → Charles Payne Demystifies Options (From Unstoppable Prosperity) (Ad) Free VCYT Stock Alerts $20.35 +0.16 (+0.79%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineVeracyte, Inc. (NASDAQ:VCYT) Shares Sold by Fisher Asset Management LLCmarketbeat.com - May 5 at 8:13 AMVeracyte (VCYT) Scheduled to Post Quarterly Earnings on Tuesdayamericanbankingnews.com - May 5 at 4:10 AMVestmark Advisory Solutions Inc. Acquires New Holdings in Veracyte, Inc. (NASDAQ:VCYT)marketbeat.com - May 4 at 2:39 PMVeracyte, Inc. (NASDAQ:VCYT) Shares Sold by New York State Common Retirement Fundmarketbeat.com - April 27 at 6:34 AMDiagnostics pioneer Bonnie Anderson launches PinkDx to focus on women's healthbizjournals.com - April 26 at 9:51 AMSemanteon Capital Management LP Makes New $1.24 Million Investment in Veracyte, Inc. (NASDAQ:VCYT)marketbeat.com - April 25 at 10:36 PMVeracyte to Release First Quarter 2024 Financial Results on May 7, 2024businesswire.com - April 22 at 5:00 PMNew Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillancefinance.yahoo.com - April 22 at 12:52 PMNew Study Shows Veracyte's Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillancebusinesswire.com - April 22 at 8:30 AMSumitomo Mitsui Trust Holdings Inc. Cuts Position in Veracyte, Inc. (NASDAQ:VCYT)marketbeat.com - April 18 at 6:13 AMVeracyte, Inc. (VCYT)finance.yahoo.com - April 17 at 10:30 AMVeracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024businesswire.com - April 16 at 8:30 AMVeracyte (NASDAQ:VCYT) Sets New 1-Year Low on Analyst Downgrademarketbeat.com - April 15 at 2:25 PMThe Goldman Sachs Group Cuts Veracyte (NASDAQ:VCYT) Price Target to $28.00marketbeat.com - April 15 at 11:21 AMMirae Asset Global Investments Co. Ltd. Sells 251,865 Shares of Veracyte, Inc. (NASDAQ:VCYT)marketbeat.com - April 14 at 5:19 AMShort Interest in Veracyte, Inc. (NASDAQ:VCYT) Increases By 32.8%marketbeat.com - April 13 at 8:33 AMVeracyte, Inc. (NASDAQ:VCYT) Stock Holdings Reduced by Assenagon Asset Management S.A.marketbeat.com - April 9 at 4:18 AMVeracyte, Inc. (NASDAQ:VCYT) Director Karin Eastham Sells 10,000 Sharesinsidertrades.com - April 3 at 5:00 AMWhat Makes Veracyte (VCYT) a Lucrative Investment?finance.yahoo.com - April 2 at 12:41 PMARK Investment Management LLC Acquires 62,011 Shares of Veracyte, Inc. (NASDAQ:VCYT)marketbeat.com - March 28 at 6:39 AMAEGON ASSET MANAGEMENT UK Plc Makes New $9.59 Million Investment in Veracyte, Inc. (NASDAQ:VCYT)marketbeat.com - March 20 at 10:49 AMWellington Management Group LLP Has $157.83 Million Holdings in Veracyte, Inc. (NASDAQ:VCYT)marketbeat.com - March 17 at 4:47 AMVCYT Apr 2024 30.000 callfinance.yahoo.com - March 16 at 10:13 AMNorthern Trust Corp Raises Position in Veracyte, Inc. (NASDAQ:VCYT)marketbeat.com - March 10 at 5:12 AMQube Research & Technologies Ltd Has $3.72 Million Stake in Veracyte, Inc. (NASDAQ:VCYT)marketbeat.com - March 8 at 5:43 AMInvesco Ltd. Grows Stock Position in Veracyte, Inc. (NASDAQ:VCYT)marketbeat.com - March 7 at 4:47 AMVeracyte, Inc. (NASDAQ:VCYT) Shares Purchased by Trexquant Investment LPmarketbeat.com - March 2 at 6:51 AMVeracyte, Inc. (NASDAQ:VCYT) Given Average Recommendation of "Moderate Buy" by Brokeragesmarketbeat.com - March 1 at 1:47 AMDark Forest Capital Management LP Makes New Investment in Veracyte, Inc. (NASDAQ:VCYT)marketbeat.com - February 29 at 5:47 AMVeracyte's Decipher Prostate Test Receives Highest Evidence-Level Rating Among Molecular Tests in Updated Prostate Cancer NCCN Guidelinesbusinesswire.com - February 27 at 5:55 PM7 Under-the-Radar Biotech Stocks Gearing Up for Liftoffinvestorplace.com - February 26 at 3:20 PMMorgan Stanley Trims Veracyte (NASDAQ:VCYT) Target Price to $21.00marketbeat.com - February 26 at 11:21 AMVeracyte’s Strategic Growth and Market Positioning Inspire Positive Analyst Outlookmarkets.businessinsider.com - February 26 at 8:22 AMVeracyte Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lagsfinance.yahoo.com - February 24 at 1:12 PM82,668 Shares in Veracyte, Inc. (NASDAQ:VCYT) Bought by Nordea Investment Management ABmarketbeat.com - February 24 at 6:01 AMAnalysts Are Bullish on Top Healthcare Stocks: Veracyte (VCYT), Irhythm Technologies (IRTC)markets.businessinsider.com - February 23 at 3:30 PMVeracyte, Inc. (NASDAQ:VCYT) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 23 at 3:30 PMVeracyte's (VCYT) "Outperform" Rating Reiterated at William Blairmarketbeat.com - February 23 at 11:45 AMNeedham & Company LLC Boosts Veracyte (NASDAQ:VCYT) Price Target to $33.00marketbeat.com - February 23 at 8:11 AMRecap: Veracyte Q4 Earningsbenzinga.com - February 22 at 7:06 PMVeracyte Inc (VCYT) Reports 22% Revenue Growth in 2023, Maintains Positive Cash Flow Outlookfinance.yahoo.com - February 22 at 7:06 PMVeracyte, Inc. 2023 Q4 - Results - Earnings Call Presentationseekingalpha.com - February 22 at 5:24 PMVeracyte Announces Fourth Quarter and Full-Year 2023 Financial Resultsbusinesswire.com - February 22 at 4:05 PMVeracyte to Participate in the Raymond James 45th Annual Institutional Investors Conferencefinance.yahoo.com - February 21 at 7:53 PMVeracyte to Participate in the Raymond James 45th Annual Institutional Investors Conferencebusinesswire.com - February 21 at 5:00 PMQRG Capital Management Inc. Takes Position in Veracyte, Inc. (NASDAQ:VCYT)marketbeat.com - February 20 at 7:04 AMVeracyte, Inc. (NASDAQ:VCYT) Shares Sold by Blair William & Co. ILmarketbeat.com - February 19 at 5:57 AMVCYT Mar 2024 35.000 putfinance.yahoo.com - February 19 at 12:52 AMVCYT Mar 2024 20.000 putfinance.yahoo.com - February 17 at 1:28 AMVeracyte (VCYT) Scheduled to Post Earnings on Thursdaymarketbeat.com - February 15 at 2:48 AM Get Veracyte News Delivered to You Automatically Sign up to receive the latest news and ratings for VCYT and its competitors with MarketBeat's FREE daily newsletter. Email Address Automatic Income (from home) (Ad)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. Just click here now to watch my presentation for free. VCYT Media Mentions By Week VCYT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VCYT News Sentiment▼0.840.42▲Average Medical News Sentiment VCYT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VCYT Articles This Week▼32▲VCYT Articles Average Week Get Veracyte News Delivered to You Automatically Sign up to receive the latest news and ratings for VCYT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Viridian Therapeutics News Today Guardant Health News Today Fulgent Genetics News Today Castle Biosciences News Today Celcuity News Today CareDx News Today Genetron News Today Burning Rock Biotech News Today Personalis News Today RadNet News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VCYT) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldAutomatic Income (from home)Awesomely, LLCThe asset beating inflation by 4xColonial MetalsCharles Payne Demystifies OptionsUnstoppable ProsperityThe A.I. story nobody is telling you (Read ASAP)TradeSmithWarren Buffet Stockpiling Gold?Reagan Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veracyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
